Skip to content

This content is in French.

Testicular Germ Cell Tumors: epidemiology, risk factors, and advances in management

28 novembre 2025

Testicular Germ Cell Tumors: epidemiology, risk factors, and advances in management

By Carolina Lima | Published on November 28, 2025 | 3 min readTesticular germ cell tumors (TGCTs) represent the most common malignancy in young men aged 15–40 years, accounting for approximately 95% of all testicular cancers. They arise from germ cells and are classified as seminomas or non-seminomatous tumors (NSGCTs), each requiring distinct treatment strategies. Despite their rarity in the gene

By Carolina Lima | Published on November 28, 2025 | 3 min read


Testicular germ cell tumors (TGCTs) represent the most common malignancy in young men aged 15–40 years, accounting for approximately 95% of all testicular cancers. They arise from germ cells and are classified as seminomas or non-seminomatous tumors (NSGCTs), each requiring distinct treatment strategies.


Despite their rarity in the general population, TGCTs are clinically significant due to their occurrence in a reproductive age group and their potential impact on fertility and long-term health. A recent review published JAMA highlights key aspects, epidemiology, risk factors, diagnosis, and therapeutic advances,

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Singla N, Bagrodia A, Baraban E, Fankhauser CD, Ged YMA. Testicular Germ Cell Tumors: A Review. JAMA. 2025;333(9):793–803. doi:10.1001/jama.2024.27122

View the source